Latest models for the discovery and development of rheumatoid arthritis drugs

References

• Smolen JS, Aletaha D, McInnes IB.Rheumatoid arthritis.Lancet.2016;388(10055):2023–2038; Epub 2016/ 10/30. PubMed PMID: 27156434;
   PubMed Web of Science ®Google Scholar
• Aletaha D, Smolen JS.Diagnosis and Management of Rheumatoid Arthritis: a Review.Jama.2018;320(13):1360–1372; Epub 2018/ 10/05. PubMed PMID: 30285183;
   PubMed Web of Science ®Google Scholar
• Myasoedova E, Crowson CS, Kremers HM, et al. Is the incidence of rheumatoid arthritis rising?: results from Olmsted County, Minnesota, 1955-2007. Arthritis Rheumatism. 2010;62(6):1576–1582.
   PubMed Web of Science ®Google Scholar
• Gabriel SE.The epidemiology of rheumatoid arthritis.Rheum Dis Clin North Am.2001;27(2):269–281; Epub 2001/ 06/09. PubMed PMID: 11396092;
   PubMed Web of Science ®Google Scholar
• McInnes IB, Schett G.The pathogenesis of rheumatoid arthritis.N Engl J Med.2011;365(23):2205–2219; Epub 2011/ 12/14. PubMed PMID: 22150039;
   PubMed Web of Science ®Google Scholar
• Das S, Padhan P.An Overview of the Extraarticular Involvement in Rheumatoid Arthritis and its Management.J Pharmacol Pharmacother.2017;8(3):81–86; Epub 2017/ 10/31. PubMed PMID: 29081614; PubMed Central PMCID: PMC5642136;
   PubMed Web of Science ®Google Scholar
• Lin Y-J, Anzaghe M, Schülke S. Update on the Pathomechanism, Diagnosis, and Treatment Options for Rheumatoid Arthritis. Cells. 2020;9(4):880. PubMed PMID: 32260219.
   PubMed Web of Science ®Google Scholar
• Giannini D, Antonucci M, Petrelli F, et al. One year in review 2020: pathogenesis of rheumatoid arthritis. Clin Exp Rheumatol. 2020;38(3):387–397. Epub 20200423. PubMed PMID: 32324123.
   PubMed Web of Science ®Google Scholar
• Deane KD, Demoruelle MK, Kelmenson LB, et al.Genetic and environmental risk factors for rheumatoid arthritis.Best Pract Res Clin Rheumatol.2017;31(1):3–18; Epub 2017/ 09/18. PubMed PMID: 29221595;
   PubMed Web of Science ®Google Scholar
• MacGregor AJ, Snieder H, Rigby AS, et al. Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins. Arthritis Rheum. 2000;43(1):30–37. PubMed PMID: 10643697.
   PubMed Web of Science ®Google Scholar
• Ham S, Bae J-B, Lee S, et al. Epigenetic analysis in rheumatoid arthritis synoviocytes. Exp Mol Med. 2019;51(2):1–13.
   Google Scholar
• Zhou S, Huang G, Chen G. The antagonistic activity of H1 receptor antagonists as medicinal foods. Trends Food SciTechnol. 2020;105:1–16.
   Web of Science ®Google Scholar
• Zhou S, Huang G, Chen G, et al. Synthesis, activity and mechanism for double-ring conjugated enones. Bioorg Med Chem Lett. 2021;49:128315.
   PubMed Web of Science ®Google Scholar
• Okada Y, Wu D, Trynka G, et al. Genetics of rheumatoid arthritis contributes to biology and drug discovery. Nature. 2014;506(7488):376–381. . PubMed PMID: 24390342; PubMed Central PMCID: PMC3944098
   PubMed Web of Science ®Google Scholar
• Gonzalez-Gay MA, Garcia-Porrua C, Hajeer AH. Influence of human leukocyte antigen-DRB1 on the susceptibility and severity of rheumatoid arthritis. Semin Arthritis Rheum. 2002;31(6):355–360. PubMed PMID: 12077707.
   PubMed Web of Science ®Google Scholar
• Zhou S, Zou H, Huang G, et al. Design, synthesis and anti-rheumatoid arthritis evaluation of double-ring conjugated enones. Bioorg Chem. 2021;109:104701.
   PubMed Web of Science ®Google Scholar
• Romo-García MF, Bastian Y, Zapata-Zuñiga M, et al. Identification of putative miRNA biomarkers in early rheumatoid arthritis by genome-wide microarray profiling: a pilot study. Gene. 2019;720:144081. Epub 20190829. .
   PubMed Web of Science ®Google Scholar
• Liu C, Pan A, Chen X, et al.MiR-5571-3p and miR-135b-5p, derived from analyses of microRNA profile sequencing, correlate with increased disease risk and activity of rheumatoid arthritis.Clin Rheumatol.2019;38(6):1753–1765; Epub 20190201. PubMed PMID: 30707326;
   PubMed Web of Science ®Google Scholar
• Meng M, Liu H, Chen S, et al. Methylation of H3K27 and H3K4 in key gene promoter regions of thymus in RA mice is involved in the abnormal development and differentiation of iNKT cells. Immunogenetics. 2019;71(7):489–499. . PubMed PMID: 31297569
   PubMed Web of Science ®Google Scholar
• Scott DL, Wolfe F, Huizinga TW.Rheumatoid arthritis.Lancet.2010;376(9746):1094–1108; Epub 2010/ 09/28. PubMed PMID: 20870100;
   PubMed Web of Science ®Google Scholar
• Derksen VFAM, Huizinga TWJ, van der Woude D.The role of autoantibodies in the pathophysiology of rheumatoid arthritis.Semin Immunopathol.2017;39(4):437–446; Epub 20170427. PubMed PMID: 28451788; PubMed Central PMCID: PMC5486798;
   PubMed Web of Science ®Google Scholar
• Schellekens GA, Visser H, de Jong BA, et al. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum. 2000;43(1):155–163. PubMed PMID: 10643712.
   PubMed Web of Science ®Google Scholar
• Wang S, Wang Y.Peptidylarginine deiminases in citrullination, gene regulation, health and pathogenesis.Biochim Biophys Acta.2013;1829(10):1126–1135; Epub 20130713. PubMed PMID: 23860259; PubMed Central PMCID: PMC3775966;
   PubMed Web of Science ®Google Scholar
• Kurowska W, Kuca-Warnawin EH, Radzikowska A, et al.The role of anti-citrullinated protein antibodies (ACPA) in the pathogenesis of rheumatoid arthritis.Cent Eur J Immunol.2017;42(4):390–398; Epub 20171230. PubMed PMID: 29472818; PubMed Central PMCID: PMC5820977.;
   PubMed Web of Science ®Google Scholar
• Kallberg H, Padyukov L, Plenge RM, et al. Gene-gene and gene-environment interactions involving HLA-DRB1, PTPN22, and smoking in two subsets of rheumatoid arthritis. Am J Hum Genet. 2007;80(5):867–875. . PubMed PMID: 17436241; PubMed Central PMCID: PMC1852748
   PubMed Web of Science ®Google Scholar
• Padyukov L, Seielstad M, Ong RT, et al. A genome-wide association study suggests contrasting associations in ACPA-positive versus ACPA-negative rheumatoid arthritis. Ann Rheum Dis. 2011;70(2):259–265. . PubMed PMID: 21156761; PubMed Central PMCID: PMC3015094
   PubMed Web of Science ®Google Scholar
• Eyre S, Bowes J, Diogo D, et al. High-density genetic mapping identifies new susceptibility loci for rheumatoid arthritis. Nat Genet. 2012;44(12):1336–1340. . PubMed PMID: 23143596; PubMed Central PMCID: PMC3605761.
   PubMed Web of Science ®Google Scholar
• Makrygiannakis D, Hermansson M, Ulfgren AK, et al. Smoking increases peptidylarginine deiminase 2 enzyme expression in human lungs and increases citrullination in BAL cells. Ann Rheum Dis. 2008;67(10):1488–1492. . PubMed PMID: 18413445
   PubMed Web of Science ®Google Scholar
• Chemin K, Gerstner C, Malmström V. Effector Functions of CD4+ T Cells at the Site of Local Autoimmune Inflammation-Lessons From Rheumatoid Arthritis. Front Immunol. 2019;10:353.
   PubMed Web of Science ®Google Scholar
• Ryu S, Lee JH, Kim SI.Kim SI. IL-17 increased the production of vascular endothelial growth factor in rheumatoid arthritis synoviocytes.Clin Rheumatol.2006;25(1):16–20; Epub 20050915. PubMed PMID: 16163444;
   PubMed Web of Science ®Google Scholar
• Zhou S, Huang G. Some important inhibitors and mechanisms of rheumatoid arthritis. Chem Biol Drug Des. 2021; Epub 20211223. doi: 10.1111/cbdd.14015. PubMed PMID: 34942050.
   Web of Science ®Google Scholar
• Redlich K, Smolen JS.Inflammatory bone loss: pathogenesis and therapeutic intervention.Nat Rev Drug Discov.2012;11(3):234–250; Epub 20120301. PubMed PMID: 22378270;
   PubMed Web of Science ®Google Scholar
• Li X, Kim KW, Cho ML, et al. IL-23 induces receptor activator of NF-kappaB ligand expression in fibroblast-like synoviocytes via STAT3 and NF-kappaB signal pathways. Immunol Lett. 2010;127(2):100–107. . PubMed PMID: 19900478
   PubMed Web of Science ®Google Scholar
• Mateen S, Zafar A, Moin S, et al. Understanding the role of cytokines in the pathogenesis of rheumatoid arthritis. Clin Chim Acta. 2016;455:161–171.
   PubMed Web of Science ®Google Scholar
• Rivellese F, Humby F, Bugatti S, et al. B Cell Synovitis and Clinical Phenotypes in Rheumatoid Arthritis: relationship to Disease Stages and Drug Exposure. Arthritis Rheumatol. 2020;72(5):714–725. . PubMed PMID: 31785084; PubMed Central PMCID: PMC7217046
   PubMed Web of Science ®Google Scholar
• Testa D, Calvacchi S, Petrelli F, et al. One year in review 2021: pathogenesis of rheumatoid arthritis. Clin Exp Rheumatol. 2021;39(3):445–452. Epub 20210521. PubMed PMID: 34018918.
   PubMed Web of Science ®Google Scholar
• Aletaha D, Neogi T, Silman AJ, et al. Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 2010;62(9):2569–2581. . PubMed PMID: 20872595
   PubMed Web of Science ®Google Scholar
• Zhou S, Zou H, Chen G, et al. Synthesis and Biological Activities of Chemical Drugs for the Treatment of Rheumatoid Arthritis. Top Curr Chem (Cham). 2019;377(5):28. Epub 20190928. .
   Google Scholar
• Smolen JS, Landewe RBM, Bijlsma JWJ, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update. Ann Rheum Dis. 2020;79(6):685–699. . PubMed PMID: 31969328
   PubMed Web of Science ®Google Scholar
• Graudal N, Hubeck-Graudal T, Faurschou M, et al. Combination Therapy With and Without Tumor Necrosis Factor Inhibitors in Rheumatoid Arthritis: a Meta-Analysis of Randomized Trials. Arthritis Care Res (Hoboken). 2015;67(11):1487–1495.
   PubMed Web of Science ®Google Scholar
• Walsh NC, Kenney LL, Jangalwe S, et al. Humanized Mouse Models of Clinical Disease. Annu Rev Pathol. 2017;12(1):187–215. . PubMed PMID: 27959627; PubMed Central PMCID: PMC5280554
   PubMedGoogle Scholar
• Grötsch B, Bozec A, Schett G. In Vivo Models of Rheumatoid Arthritis. Methods Mol Biol. 2019;1914:269–280. PubMed PMID: 30729470.
   PubMedGoogle Scholar
• Damerau A, Gaber T.Modeling Rheumatoid Arthritis In Vitro: from Experimental Feasibility to Physiological Proximity.Int J Mol Sci.2020;21(21):7916; Epub 20201025. PubMed PMID: 33113770; PubMed Central PMCID: PMC7663779;
   PubMed Web of Science ®Google Scholar
• Asquith DL, Miller AM, McInnes IB, et al. Animal models of rheumatoid arthritis. Eur J Immunol. 2009;39(8):2040–2044. PubMed PMID: 19672892.
   PubMed Web of Science ®Google Scholar
• Choudhary N, Bhatt LK, Prabhavalkar KS.Experimental animal models for rheumatoid arthritis.Immunopharmacol Immunotoxicol.2018;40(3):193–200; Epub 20180212. PubMed PMID: 29433367.;
   PubMed Web of Science ®Google Scholar
• Perrin S. Preclinical research: make mouse studies work. Nature. 2014;507(7493):423–425. PubMed PMID: 24678540.
   PubMed Web of Science ®Google Scholar
• Schinnerling K, Rosas C, Soto L, et al. Humanized Mouse Models of Rheumatoid Arthritis for Studies on Immunopathogenesis and Preclinical Testing of Cell-Based Therapies. Front Immunol. 2019;10:203. PubMed PMID: 30837986.
   PubMed Web of Science ®Google Scholar
• Lubberts E, Koenders MI, Oppers-Walgreen B, et al. Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion. Arthritis Rheum. 2004;50(2):650–659. PubMed PMID: 14872510.
   PubMed Web of Science ®Google Scholar
• Joosten LA, Helsen MM, van de Loo FA, et al. Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice. A comparative study using anti-TNF alpha, anti-IL-1 alpha/beta, and IL-1Ra. Arthritis Rheum. 1996;39(5):797–809. PubMed PMID: 8639177.
   PubMed Web of Science ®Google Scholar
• Pavelka K, Chon Y, Newmark R, et al.A study to evaluate the safety, tolerability, and efficacy of brodalumab in subjects with rheumatoid arthritis and an inadequate response to methotrexate.J Rheumatol.2015;42(6):912–919; Epub 20150415. PubMed PMID: 25877498;
   PubMed Web of Science ®Google Scholar
• Gabay C, Lamacchia C, Palmer G.IL-1 pathways in inflammation and human diseases.Nat Rev Rheumatol.2010;6(4):232–241; Epub 20100223. PubMed PMID: 20177398.;
   PubMed Web of Science ®Google Scholar
• Cassotta M, Pistollato F, Battino M.Rheumatoid arthritis research in the 21st century: limitations of traditional models, new technologies, and opportunities for a human biology-based approach.ALTEX 2020;37(2):223–242; Epub 20191217. PubMed PMID: 31854453.;
   PubMedGoogle Scholar
• Scott LJ. Tocilizumab: a Review in Rheumatoid Arthritis. Drugs. 2017;77(17):1865–1879. PubMed PMID: 29094311; PubMed Central PMCID: PMC5736769.
   PubMed Web of Science ®Google Scholar
• Bessis N, Decker P, Assier E, et al.Arthritis models: usefulness and interpretation.Semin Immunopathol.2017;39(4):469–486; Epub 20170327. PubMed PMID: 28349194;
   PubMed Web of Science ®Google Scholar
• Williams RO, Feldmann M, Maini RN. Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis. Proc Natl Acad Sci U S A. 1992;89(20):9784–9788. PubMed PMID: 1409699; PubMed Central PMCID: PMC50217.
   PubMed Web of Science ®Google Scholar
• Zhao S, Mysler E, Moots RJ.Etanercept for the treatment of rheumatoid arthritis.Immunotherapy.2018;10(6):433–445; Epub 20180227. PubMed PMID: 29482402;
   PubMed Web of Science ®Google Scholar
• Alldred A. Etanercept in rheumatoid arthritis. Expert Opin Pharmacother. 2001;2(7):1137–1148. PubMed PMID: 11583065.
   PubMedGoogle Scholar
• Wooley PH, Dutcher J, Widmer MB, et al. Influence of a recombinant human soluble tumor necrosis factor receptor FC fusion protein on type II collagen-induced arthritis in mice. J Immunol. 1993;151(11):6602–6607. PubMed PMID: 8245488.
   PubMed Web of Science ®Google Scholar
• Vignali DA, Moreno J, Schiller D, et al. Species-specific binding of CD4 to the beta 2 domain of major histocompatibility complex class II molecules. J Exp Med. 1992;175(4):925–932.
   PubMed Web of Science ®Google Scholar
• Fugger L, Michie SA, Rulifson I, et al. Expression of HLA-DR4 and human CD4 transgenes in mice determines the variable region beta-chain T-cell repertoire and mediates an HLA-DR-restricted immune response. Proc Natl Acad Sci U S A. 1994;91(13):6151–6155. PubMed PMID: 8016129; PubMed Central PMCID: PMC44156.
   PubMed Web of Science ®Google Scholar
• Ito K, Bian HJ, Molina M, et al. HLA-DR4-IE chimeric class II transgenic, murine class II-deficient mice are susceptible to experimental allergic encephalomyelitis. J Exp Med. 1996;183(6):2635–2644. PubMed PMID: 8676084; PubMed Central PMCID: PMC2192625.
   PubMed Web of Science ®Google Scholar
• Rosloniec EF, Brand DD, Myers LK, et al. An HLA-DR1 transgene confers susceptibility to collagen-induced arthritis elicited with human type II collagen. J Exp Med. 1997;185(6):1113–1122. PubMed PMID: 9091584; PubMed Central PMCID: PMC2196244.
   PubMed Web of Science ®Google Scholar
• Andersson EC, Hansen BE, Jacobsen H, et al. Definition of MHC and T cell receptor contacts in the HLA-DR4restricted immunodominant epitope in type II collagen and characterization of collagen-induced arthritis in HLA-DR4 and human CD4 transgenic mice. Proc Natl Acad Sci U S A. 1998;95(13):7574–7579. PubMed PMID: 9636191; PubMed Central PMCID: PMC22687.
   PubMed Web of Science ®Google Scholar
• Cheng S, Baisch J, Krco C, et al. Expression and function of HLA-DQ8 (DQA1*0301/DQB1*0302) genes in transgenic mice. Eur J Immunogenet. 1996;23(1):15–20. PubMed PMID: 8834919.
   PubMedGoogle Scholar
• Taneja V, Behrens M, Mangalam A, et al. New humanized HLA-DR4-transgenic mice that mimic the sex bias of rheumatoid arthritis. Arthritis Rheum. 2007;56(1):69–78. PubMed PMID: 17195209.
   PubMed Web of Science ®Google Scholar
• Snir O, Rieck M, Gebe JA, et al. Identification and functional characterization of T cells reactive to citrullinated vimentin in HLA-DRB1*0401-positive humanized mice and rheumatoid arthritis patients. Arthritis Rheum. 2011;63(10):2873–2883. PubMed PMID: 21567378; PubMed Central PMCID: PMC3174345.
   PubMedGoogle Scholar
• Latham KA, Whittington KB, Zhou R, et al. Ex vivo characterization of the autoimmune T cell response in the HLA-DR1 mouse model of collagen-induced arthritis reveals long-term activation of type II collagen-specific cells and their presence in arthritic joints. J Immunol. 2005;174(7):3978–3985. PubMed PMID: 15778354.
   PubMed Web of Science ®Google Scholar
• Miller DC, Whittington KB, Brand DD, et al.The CII-specific autoimmune T-cell response develops in the presence of FTY720 but is regulated by enhanced Treg cells that inhibit the development of autoimmune arthritis.Arthritis Res Ther.2016;18(1):8; Epub 20160112. PubMed PMID: 26757712; PubMed Central PMCID: PMC4718028;
   PubMedGoogle Scholar
• Yue D, Brintnell W, Mannik LA, et al. CTLA-4Ig blocks the development and progression of citrullinated fibrinogen-induced arthritis in DR4-transgenic mice. Arthritis Rheum. 2010;62(10):2941–2952. PubMed PMID: 20533540.
   PubMed Web of Science ®Google Scholar
• Blair HA, Deeks ED, Blair HA, et al. Abatacept: a Review in Rheumatoid Arthritis. Drugs. 2017;77(11):1221–1233. PubMed PMID: 28608166.
   PubMed Web of Science ®Google Scholar
• Malmström V, Ho KK, Lun J, et al. Arthritis susceptibility in mice expressing human type II collagen in cartilage. Scand J Immunol. 1997;45(6):670–677. PubMed PMID: 9201307.
   PubMed Web of Science ®Google Scholar
• Berlo SE, Guichelaar T, Ten Brink CB, et al. Increased arthritis susceptibility in cartilage proteoglycan–specific T cell receptor–transgenic mice. Arthritis Rheum. 2006;54(8):2423–2433. PubMed PMID: 16869010.
   PubMedGoogle Scholar
• Batsalova T, Dzhambazov B, Merky P, et al. T cell tolerance against self type II collagen in HLA-DR4-transgenic mice and development of autoimmune arthritis. Arthritis Rheum. 2010;62(7):1911–1920. PubMed PMID: 20309862.
   PubMedGoogle Scholar
• Theocharides AP, Rongvaux A, Fritsch K, et al. Humanized hemato-lymphoid system mice. Haematologica. 2016;101(1):5–19. PubMed PMID: 26721800; PubMed Central PMCID: PMC4697887.
   PubMed Web of Science ®Google Scholar
• Bosma GC, Custer RP, Bosma MJ. A severe combined immunodeficiency mutation in the mouse. Nature. 1983;301(5900):527–530. PubMed PMID: 6823332.
   PubMed Web of Science ®Google Scholar
• Shultz LD, Brehm MA, Garcia-Martinez JV, et al.Humanized mice for immune system investigation: progress, promise and challenges.Nat Rev Immunol.2012;12(11):786–798; Epub 20121012. PubMed PMID: 23059428; PubMed Central PMCID: PMC3749872;
   PubMed Web of Science ®Google Scholar
• Watanabe S, Ohta S, Yajima M, et al. Humanized NOD/SCID/IL2Rgamma(null) mice transplanted with hematopoietic stem cells under nonmyeloablative conditions show prolonged life spans and allow detailed analysis of human immunodeficiency virus type 1 pathogenesis. J Virol. 2007;81(23):13259–13264. . PubMed PMID: 17881441; PubMed Central PMCID: PMC2169100
   PubMed Web of Science ®Google Scholar
• Tighe H, Silverman GJ, Kozin F, et al. Autoantibody production by severe combined immunodeficient mice reconstituted with synovial cells from rheumatoid arthritis patients. Eur J Immunol. 1990;20(8):1843–1848. PubMed PMID: 2209691.
   PubMed Web of Science ®Google Scholar
• Misharin AV, Haines GK, Rose S, et al.Development of a new humanized mouse model to study acute inflammatory arthritis.J Transl Med.2012;10(1):190; Epub 20120913. PubMed PMID: 22974474; PubMed Central PMCID: PMC3480927;
   PubMedGoogle Scholar
• Sack U, Kuhn H, Ermann J, et al. Synovial tissue implants from patients with rheumatoid arthritis cause cartilage destruction in knee joints of SCID.bg mice. J Rheumatol. 1994;21(1):10–16. PubMed PMID: 8151561.
   PubMed Web of Science ®Google Scholar
• Lefèvre S, Knedla A, Tennie C, et al. Synovial fibroblasts spread rheumatoid arthritis to unaffected joints. Nat Med. 2009;15(12):1414–1420. . PubMed PMID: 19898488; PubMed Central PMCID: PMC3678354
   PubMed Web of Science ®Google Scholar
• Greenblatt MB, Vrbanac V, Vbranac V, et al. Graft versus host disease in the bone marrow, liver and thymus humanized mouse model. PLoS One. 2012;7(9):e44664. . PubMed PMID: 22957096; PubMed Central PMCID: PMC3434179
   PubMed Web of Science ®Google Scholar
• Lockridge JL, Zhou Y, Becker YA, et al. Mice engrafted with human fetal thymic tissue and hematopoietic stem cells develop pathology resembling chronic graft-versus-host disease. Biol Blood Marrow Transplant. 2013;19(9):1310–1322. . PubMed PMID: 23806772; PubMed Central PMCID: PMC3755109
   PubMed Web of Science ®Google Scholar
• Häupl T, Yahyawi M, Lübke C, et al. Gene expression profiling of rheumatoid arthritis synovial cells treated with antirheumatic drugs. J Biomol Screen. 2007;12(3):328–340. . PubMed PMID: 17379860
   PubMedGoogle Scholar
• Damerau A, Gaber T. Modeling Rheumatoid Arthritis In Vitro: from Experimental Feasibility to Physiological Proximity. Int J Mol Sci. 2020;21(21):1–25.
   Web of Science ®Google Scholar
• Xie Q, Xu WD, Pan M, et al. Association of IL-35 expression and gene polymorphisms in rheumatoid arthritis. Int Immunopharmacol. 2021;90. 10.1016/J.INTIMP.2020.107231.
   Web of Science ®Google Scholar
• Pagani S, Torricelli P, Veronesi F, et al. An advanced tri-culture model to evaluate the dynamic interplay among osteoblasts, osteoclasts, and endothelial cells. J Cell Physiol. 2018;233(1):291–301.
   PubMed Web of Science ®Google Scholar
• Neumann E, Riepl B, Knedla A, et al. Cell culture and passaging alters gene expression pattern and proliferation rate in rheumatoid arthritis synovial fibroblasts. Arthritis Res Therapy. 2010;12(3):1–10.
   Web of Science ®Google Scholar
• Kapałczyńska M, Kolenda T, Przybyła W, et al. 2D and 3D cell cultures – a comparison of different types of cancer cell cultures. Arch Med Sci. 2018;14(4):910.
   PubMed Web of Science ®Google Scholar
• Pampaloni F, Reynaud EG, Stelzer EH. The third dimension bridges the gap between cell culture and live tissue. Nat Rev Mol Cell Biol. 2007;8(10):839–845. PubMed PMID: 17684528.
   PubMed Web of Science ®Google Scholar
• Von Der Mark K, Gauss V, Von Der Mark H, et al. Relationship between cell shape and type of collagen synthesised as chondrocytes lose their cartilage phenotype in culture. Nature. 1977;267(5611):531–532.
   PubMed Web of Science ®Google Scholar
• Hall AC.The Role of Chondrocyte Morphology and Volume in Controlling Phenotype-Implications for Osteoarthritis, Cartilage Repair, and Cartilage Engineering.Curr Rheumatol Rep.2019;21(8):38; Epub 20190615. PubMed PMID: 31203465; PubMed Central PMCID: PMC6571082;
   PubMed Web of Science ®Google Scholar
• Goldring MB Human Chondrocyte Cultures as Models of Cartilage-Specific Gene Regulation. Human Cell Culture Protocols: Humana Press. p. 069–96.
   Google Scholar
• Penolazzi L, Lambertini E, Piva R. The Adequacy of Experimental Models and Understanding the Role of Non-coding RNA in Joint Homeostasis and Disease. Front Genet. 2020;11:11.
   PubMed Web of Science ®Google Scholar
• Baker BM, Chen CS. Deconstructing the third dimension – how 3D culture microenvironments alter cellular cues. J Cell Sci. 2012;125(13):3015–3024.
   PubMed Web of Science ®Google Scholar
• Kim K, Bou-Ghannam S, Thorp H, et al. Human mesenchymal stem cell sheets in xeno-free media for possible allogenic applications. Sci Rep. 2019;9(1):14415.
   PubMedGoogle Scholar
• Weber M-C, Fischer L, Damerau A, et al. Macroscale mesenchymal condensation to study cytokine-driven cellular and matrix-related changes during cartilage degradation. Biofabrication. 2020;12(4):45016.
   Web of Science ®Google Scholar
• Bicho D, Pina S, Oliveira JM, et al. In Vitro Mimetic Models for the Bone-Cartilage Interface Regeneration. Adv Exp Med Biol. 2018;1059:373–394. PubMed PMID: 29736583.
   PubMed Web of Science ®Google Scholar
• Owen R, Reilly GC, Zwick M. In vitro Models of Bone Remodelling and Associated Disorders. Front Bioeng Biotechnol. 2018;6:6.
   PubMed Web of Science ®Google Scholar
• Park JY, Park SH, Kim MG, et al. Biomimetic Scaffolds for Bone Tissue Engineering. (0065-2598 (Print)).
   Google Scholar
• Dhivya S, Saravanan S, Sastry TP, et al. Nanohydroxyapatite-reinforced chitosan composite hydrogel for bone tissue repair in vitro and in vivo. J Nanobiotechnology. 2015;13(1):40.
   PubMedGoogle Scholar
• Scheinpflug J, Pfeiffenberger M, Damerau A, et al. Journey into Bone Models: a Review. Genes (Basel). 2018;9(5):247. PubMed PMID.
   PubMed Web of Science ®Google Scholar
• Zeng Y, Hoque J, Varghese S. Biomaterial-assisted local and systemic delivery of bioactive agents for bone repair. Acta Biomater. 2019;93:152–168.
   PubMed Web of Science ®Google Scholar
• Mazzei D, Guzzardi MA, Giusti S, et al. A low shear stress modular bioreactor for connected cell culture under high flow rates. Biotechnol Bioeng. 2010;106(1):127–137.
   PubMed Web of Science ®Google Scholar
• Mattei G, Giusti S, Ahluwalia A. Design Criteria for Generating Physiologically Relevant In Vitro Models in Bioreactors. Processes. 2014;2(3):548–569. PubMed PMID.
   Google Scholar
• Giusti S, Pagliari F, Vozzi F, et al. SQPR 3.0: a Sensorized Bioreactor for Modulating Cardiac Phenotype. Procedia Eng. 2013;59:219–225.
   Google Scholar
• De Maria C, Giusti S, Mazzei D, et al. Squeeze pressure bioreactor: a hydrodynamic bioreactor for noncontact stimulation of cartilage constructs. Tissue Eng Part C Methods. 2011;17(7):757–764.
   PubMed Web of Science ®Google Scholar
• Bader DL, Salter DM, Chowdhury TT. Biomechanical Influence of Cartilage Homeostasis in Health and Disease. Arthritis. 2011;2011:979032.
   PubMedGoogle Scholar
• Baker M. Reproducibility: respect your cells! Nature. Nature. 2016;537(7620):433–435.
   PubMed Web of Science ®Google Scholar
• Mazzei D, Vozzi F, Cisternino A, et al. System for Simulating Physiological Environments. IEEE Trans Ind Electron. 2008;55(9):3273–3280.
   Web of Science ®Google Scholar
• Giusti S, Mazzei D, Cacopardo L, et al. Environmental Control in Flow Bioreactors. Processes. 2017;5(2):16. PubMed PMID.
   Web of Science ®Google Scholar
• Ibold Y, Frauenschuh S, Kaps C, et al. Development of a High-Throughput Screening Assay Based on the 3-Dimensional Pannus Model for Rheumatoid Arthritis. J Biomol Screen. 2007;12(7):956–965. PubMed PMID: 17942788.
   PubMedGoogle Scholar
• Peck Y, Leom LT, Low PFP, et al. Establishment of an in vitro three-dimensional model for cartilage damage in rheumatoid arthritis. J Tissue Eng Regen Med. 2018;12(1):e237–e49.
   PubMed Web of Science ®Google Scholar
• Smith MD.The normal synovium.Open Rheumatol J.2011;5(1):100–106; Epub 20111230. PubMed PMID: 22279508; PubMed Central PMCID: PMC3263506;
   PubMedGoogle Scholar
• Kiener HP, Watts GFM, Cui Y, et al. Synovial fibroblasts self-direct multicellular lining architecture and synthetic function in three-dimensional organ culture. Arthritis Rheumatism. 2010;62(3):742–752.
   PubMedGoogle Scholar
• Karonitsch T, Beckmann D, Dalwigk K, et al. Targeted inhibition of Janus kinases abates interfon gamma-induced invasive behaviour of fibroblast-like synoviocytes. Rheumatology. 2017;57(3):572–577.
   Web of Science ®Google Scholar
• Bonelli M, Dalwigk K, Platzer A, et al. IRF1 is critical for the TNF-driven interferon response in rheumatoid fibroblast-like synoviocytes. Exp Mol Med. 2019;51(7):1–11.
   PubMedGoogle Scholar
• Broeren MGA, Waterborg CEJ, Wiegertjes R, et al. A three-dimensional model to study human synovial pathology. Altex. 2019;36(1):18–28. . PubMed PMID: 30303512
   PubMedGoogle Scholar
• Denu RA, Nemcek S, Bloom DD, et al. Fibroblasts and Mesenchymal Stromal/Stem Cells Are Phenotypically Indistinguishable. Acta Haematol. 2016;136(2):85–97.
   PubMed Web of Science ®Google Scholar
• Carballo CB, Nakagawa Y, Sekiya I, et al. Basic Science of Articular Cartilage. Clin Sports Med. 2017;36(3):413–425.
   PubMed Web of Science ®Google Scholar
• Adán N, Guzmán-Morales J, Ledesma-Colunga MG, et al. Prolactin promotes cartilage survival and attenuates inflammation in inflammatory arthritis. J Clin Invest. 2013;123(9):3902–3913.
   PubMed Web of Science ®Google Scholar
• Schuerwegh AJ, Dombrecht EJ, Stevens WJ, et al. Influence of pro-inflammatory (IL-1α, IL-6, TNF-α, IFN-γ) and anti-inflammatory (IL-4) cytokines on chondrocyte function. Osteoarthritis Cartilage. 2003;11(9):681–687.
   PubMed Web of Science ®Google Scholar
• Zhang W, Chen J, Tao J, et al. The use of type 1 collagen scaffold containing stromal cell-derived factor-1 to create a matrix environment conducive to partial-thickness cartilage defects repair. Biomaterials. 2013;34(3):713–723.
   PubMed Web of Science ®Google Scholar
• Park H, Choi B, Hu J, et al. Injectable chitosan hyaluronic acid hydrogels for cartilage tissue engineering. Acta Biomater. 2013;9(1):4779–4786.
   PubMed Web of Science ®Google Scholar
• Andreas K, Lübke C, Häupl T, et al. Key regulatory molecules of cartilage destruction in rheumatoid arthritis: an in vitrostudy. Arthritis Res Ther. 2008;10(1):R9–R.
   PubMed Web of Science ®Google Scholar
• Sato M, Yamato M, Hamahashi K, et al. Articular Cartilage Regeneration Using Cell Sheet Technology. Anat Rec. 2014;297(1):36–43.
   Google Scholar
• Furukawa KS, Suenaga H, Toita K, et al. Rapid and Large-Scale Formation of Chondrocyte Aggregates by Rotational Culture. Cell Transplant. 2003;12(5):475–479. PubMed PMID: 12953921.
   PubMed Web of Science ®Google Scholar
• Penick KJ, Solchaga LA, Welter JF. High-throughput aggregate culture system to assess the chondrogenic potential of mesenchymal stem cells. BioTechniques. 2005;39(5):687–691. PubMed PMID: 16312217.
   PubMed Web of Science ®Google Scholar
• Zhang S, Ba K, Wu L, et al. Adventitial Cells and Perictyes Support Chondrogenesis Through Different Mechanisms in 3-Dimensional Cultures With or Without Nanoscaffolds. J Biomed Nanotechnol. 2015;11(10):1799–1807. PubMed PMID: 26502642.
   PubMed Web of Science ®Google Scholar
• Sanjurjo-Rodríguez C, Castro-Viñuelas R, Hermida-Gómez T, et al. Human Cartilage Engineering in an In Vitro Repair Model Using Collagen Scaffolds and Mesenchymal Stromal Cells. Int J Med Sci. 2017;14(12):1257–1262.
   PubMed Web of Science ®Google Scholar
• Ando W, Tateishi K, Katakai D; In Vitro Generation of a Scaffold-Free Tissue-Engineered Construct (TEC) Derived from Human Synovial Mesenchymal Stem Cells: Biological and Mechanical Properties and Further Chondrogenic Potential. Tissue Engineering Part A. In vitro generation of a scaffold-free tissue-engineered construct (TEC) derived from human synovial mesenchymal stem cells: biological and mechanical properties and further chondrogenic potential. Tissue Engineering. Part A. 2008;14(12):2041–2049. PubMed PMID: 18636944.
   PubMed Web of Science ®Google Scholar
• Ghassemi T, Shahroodi A, Ebrahimzadeh MH, et al. Current Concepts in Scaffolding for Bone Tissue Engineering. Arch Bone Jt Surg. 2018;6(2): 90–99 .
   PubMedGoogle Scholar
• Bendtsen ST, Quinnell SP, Wei M. Development of a novel alginate-polyvinyl alcohol-hydroxyapatite hydrogel for 3D bioprinting bone tissue engineered scaffolds. J Biomed Mater Res A. 2017;105(5):1457–1468.
   PubMed Web of Science ®Google Scholar
• Agarwal T, Kabiraj P, Narayana GH, et al. Alginate Bead Based Hexagonal Close Packed 3D Implant for Bone Tissue Engineering. ACS Appl Mater Interfaces. 2016;8(47):32132–32145.
   PubMed Web of Science ®Google Scholar
• T-m DW, Fratila-Apachitei LE, Zadpoor AA, et al. Bone tissue engineering via growth factor delivery: from scaffolds to complex matrices. Regen Biomater. 2018;5(4):197–211.
   PubMed Web of Science ®Google Scholar
• Fernandes G, Wang C, Yuan X, et al. Combination of Controlled Release Platelet-Rich Plasma Alginate Beads and Bone Morphogenetic Protein-2 Genetically Modified Mesenchymal Stem Cells for Bone Regeneration. J Periodontol. 2016;87(4):470–480.
   PubMed Web of Science ®Google Scholar
• Deng Y, Jiang C, Li C, et al. 3D printed scaffolds of calcium silicate-doped β-TCP synergize with co-cultured endothelial and stromal cells to promote vascularization and bone formation. Sci Rep. 2017;7(1):5588.
   PubMedGoogle Scholar
• Chiesa I, De Maria C, Lapomarda A, et al. Endothelial cells support osteogenesis in an in vitro vascularized bone model developed by 3D bioprinting. Biofabrication. 2020;12(2):025013. . PubMed PMID: 31929117
   PubMed Web of Science ®Google Scholar
• Ng J, Bernhard J, Mesenchymal Stem V-NG Cells for Osteochondral Tissue Engineering. (1940-6029 (Electronic)).
   Google Scholar
• Lin Z, Li Z, Li EN, et al. Osteochondral Tissue Chip Derived From iPSCs: modeling OA Pathologies and Testing Drugs. Front Bioeng Biotechnol. 2019;7:7.
   PubMed Web of Science ®Google Scholar
• Potter SJ, Using DT. Ex Vivo Upright Droplet Cultures of Whole Fetal Organs to Study Developmental Processes during Mouse Organogenesis. J Visualized Exp. 2015;(104). DOI:10.3791/53262.
   Web of Science ®Google Scholar
• Seibl R, Birchler T, Loeliger S, et al. Expression and Regulation of Toll-Like Receptor 2 in Rheumatoid Arthritis Synovium. Am J Pathol. 2003;162(4):1221–1227.
   PubMed Web of Science ®Google Scholar
• Ultaigh SN, Saber TP, McCormick J, et al. Blockade of Toll-like receptor 2 prevents spontaneous cytokine release from rheumatoid arthritis ex vivo synovial explant cultures. Arthritis Res Ther. R33.Epub 20110223. doi: 10.1186/ar3261. PubMed PMID: 21345222; PubMed Central PMCID: PMC3241377. 2011;13(1).
   PubMed Web of Science ®Google Scholar
• Nic An Ultaigh S, Saber, Mccormick J, et al. Blockade of Toll-like receptor 2 prevents spontaneous cytokine release from rheumatoid arthritis ex vivo synovial explant cultures. Arthritis Res Ther. 2011;13(1):R33.
   PubMed Web of Science ®Google Scholar
• Gang F, Zhang Q, Jiang L, et al. Thermochemotherapy Meets Tissue Engineering for Rheumatoid Arthritis Treatment (Adv. Funct. Mater. 40/2021). Adv Funct Mater. 2021;31(40):2170295.
   Web of Science ®Google Scholar
• Tew SR, Kwan APL, Hann A, et al. The reactions of articular cartilage to experimental wounding: role of apoptosis. Arthritis Rheumatism. 2000;43(1):215–225.
   PubMed Web of Science ®Google Scholar
• Gilbert SJ, Singhrao SK, Khan IM, et al. Enhanced Tissue Integration During Cartilage Repair In Vitro Can Be Achieved by Inhibiting Chondrocyte Death at the Wound Edge. Tissue Eng Part A. 2009;15(7):1739–1749.
   PubMed Web of Science ®Google Scholar
• Marino S, Staines KA, Brown G, et al. Models of ex vivo explant cultures: applications in bone research. Bonekey Rep. 2016;5:818.
   PubMedGoogle Scholar
• Jodat AY, Kang GM, Kiaee K, et al. Human-Derived Organ-on-a-Chip for Personalized Drug Development. Curr Pharm Des. 2018;24(45):5471–5486.
   PubMed Web of Science ®Google Scholar
• Seidi S, Eftekhari A, Khusro A, et al. Simulation and modeling of physiological processes of vital organs in organ-on-a-chip biosystem. J King Saud Univ Sci. 2022;34(1):101710.
   Web of Science ®Google Scholar
• Rajan SAP, Aleman J, Wan M, et al. Probing prodrug metabolism and reciprocal toxicity with an integrated and humanized multi-tissue organ-on-a-chip platform. Acta Biomater. 2020;106:124–135.
   PubMed Web of Science ®Google Scholar
• Rosser J, Bachmann B, Jordan C, et al. Microfluidic nutrient gradient–based three-dimensional chondrocyte culture-on-a-chip as an in vitro equine arthritis model. Mater Today Bio. 2019;4:100023.
   PubMedGoogle Scholar
• Rothbauer M, Höll G Fau - Eilenberger C, Eilenberger C Fau - Kratz SRA, et al. Monitoring tissue-level remodelling during inflammatory arthritis using a three-dimensional synovium-on-a-chip with non-invasive light scattering biosensing. (Electronic). 1473
   Google Scholar
• Ma H-P, Deng X, Chen D-Y, et al. A microfluidic chip-based co-culture of fibroblast-like synoviocytes with osteoblasts and osteoclasts to test bone erosion and drug evaluation. R Soc Open Sci. 2018;5(9):180528.
   PubMed Web of Science ®Google Scholar
• Occhetta P, Mainardi A, Votta E, et al. Hyperphysiological compression of articular cartilage induces an osteoarthritic phenotype in a cartilage-on-a-chip model. Nat Biomed Eng. 2019;3(7):545–557.
   PubMed Web of Science ®Google Scholar
• Knowlton S, Tasoglu S. A Bioprinted Liver-on-a-Chip for Drug Screening Applications. Trends Biotechnol. 2016;34(9):681–682.
   PubMed Web of Science ®Google Scholar
• Lee J, Kidney-on-a-Chip: KS, New A. Technology for Predicting Drug Efficacy, Interactions, and Drug-induced Nephrotoxicity. Curr Drug Metab. 2018;19(7):577–583.
   PubMed Web of Science ®Google Scholar
• Zhang YS, Aleman J, Arneri A, et al. From cardiac tissue engineering to heart-on-a-chip: beating challenges. Biomed Mater. 2015;10(3):034006.
   PubMed Web of Science ®Google Scholar
• Wikswo JP. The relevance and potential roles of microphysiological systems in biology and medicine. Exp Biol Med. 2014;239(9):1061–1072. PubMed PMID: 25187571.
   PubMed Web of Science ®Google Scholar
• Schork NJ. Personalized medicine: time for one-person trials. Nature. 2015;520(7549):609–611.
   PubMed Web of Science ®Google Scholar
• Strand V, Tundia N, Song Y, et al. Economic Burden of Patients with Inadequate Response to Targeted Immunomodulators for Rheumatoid Arthritis. J Manag Care Spec Pharm. 2018;24(4):344–352.
   PubMed Web of Science ®Google Scholar
• Romão VC, Canhão H, Fonseca JE. Old drugs, old problems: where do we stand in prediction of rheumatoid arthritis responsiveness to methotrexate and other synthetic DMARDs? BMC Med. 2013;11:17. Epub 20130123. ; PubMed Central PMCID: PMC3606422.
   PubMed Web of Science ®Google Scholar
• Mestres G, Perez RA, D’Elía NL, et al. Advantages of microfluidic systems for studying cell-biomaterial interactions—focus on bone regeneration applications. Biomed Phys Eng Express. 2019;5(3):032001.
   Web of Science ®Google Scholar
• Halldorsson S, Lucumi E, Gómez-Sjöberg R, et al. Advantages and challenges of microfluidic cell culture in polydimethylsiloxane devices. Biosens Bioelectron. 2015;63:218–231.
   PubMed Web of Science ®Google Scholar
• Sosa-Hernández JE, Villalba-Rodríguez AM, Romero-Castillo KD, et al. Organs-on-a-Chip Module: a Review from the Development and Applications Perspective. Micromachines. 2018;9(10):536. PubMed PMID:.
   PubMed Web of Science ®Google Scholar
• Luni C, Serena E, Elvassore N. Human-on-chip for therapy development and fundamental science. Curr Opin Biotechnol. 2014;25:45–50.
   PubMed Web of Science ®Google Scholar
• Weibel DB, Whitesides GM. Applications of microfluidics in chemical biology. Curr Opin Chem Biol. 2006;10(6):584–591.
   PubMed Web of Science ®Google Scholar
• Noh J, Kim Hc Fau - Chung TD, Chung TD. Biosensors in microfluidic chips. (0340-1022 (Print)).
   Google Scholar
• Sackmann EK, Fulton AL, Beebe DJ. The present and future role of microfluidics in biomedical research. Nature. 2014;507(7491):181–189.
   PubMed Web of Science ®Google Scholar
• Shanti A, Teo J, Stefanini C. In Vitro Immune Organs-on-Chip for Drug Development: a Review. Pharmaceutics. 2018;10(4):278. PubMed PMID.
   PubMed Web of Science ®Google Scholar
• Takahashi K, Tanabe K, Ohnuki M, et al.Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007;131(5):861–872. PubMed PMID: 18035408
   PubMed Web of Science ®Google Scholar
• Chang SK, Gu Z, Brenner MB. Fibroblast-like synoviocytes in inflammatory arthritis pathology: the emerging role of cadherin-11. Immunol Rev. 2010;233(1):256–266. PubMed PMID: 20193004.
   PubMed Web of Science ®Google Scholar
• Bartok B, Firestein GS. Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis. Immunol Rev. 2010;233(1):233–255. PubMed PMID: 20193003; PubMed Central PMCID: PMC2913689.
   PubMed Web of Science ®Google Scholar
• Rim YA, Park N, Nam Y, et al. Generation of Induced-pluripotent Stem Cells Using Fibroblast-like Synoviocytes Isolated from Joints of Rheumatoid Arthritis Patients. J Vis Exp. 2016;(116). Epub 20161016. doi: 10.3791/54072. PubMed PMID: 27805584; PubMed Central PMCID: PMC5092200.
   Web of Science ®Google Scholar
• Wang L, Cong X, Liu G, et al. Human umbilical cord mesenchymal stem cell therapy for patients with active rheumatoid arthritis: safety and efficacy. Stem Cells Dev. 2013;22(24):3192–3202. . PubMed PMID: 23941289
   PubMed Web of Science ®Google Scholar
• Witten TM, Del Rincon I, Escalante A. Modeling the progression of articular erosion in rheumatoid arthritis (RA): initial mathematical models. MathComput Modell. 2000;31(2):31–38.
   Google Scholar
• Jit M, Henderson B, Stevens M, et al.TNF-alpha neutralization in cytokine-driven diseases: a mathematical model to account for therapeutic success in rheumatoid arthritis but therapeutic failure in systemic inflammatory response syndrome.Rheumatology (Oxford).2005;44(3):323–331; Epub 20041207. PubMed PMID: 15585509;
   PubMed Web of Science ®Google Scholar
• Baker M, Denman-Johnson S, Brook BS, et al. Mathematical modelling of cytokine-mediated inflammation in rheumatoid arthritis. Math Med Biol. 2013;30(4):311–337. Epub 20120920. .
   Google Scholar
• Lacroix BD, Lovern MR, Stockis A, et al.A pharmacodynamic Markov mixed-effects model for determining the effect of exposure to certolizumab pegol on the ACR20 score in patients with rheumatoid arthritis.Clin Pharmacol Ther.2009;86(4):387–395; Epub 20090722. PubMed PMID: 19626001;
   PubMed Web of Science ®Google Scholar
• Moise N, Friedman A. Rheumatoid arthritis - a mathematical model. J Theor Biol. 2019;461:17–33. Epub 20181019. .
   PubMed Web of Science ®Google Scholar
• McInnes IB, Schett G. Cytokines in the pathogenesis of rheumatoid arthritis. Nat Rev Immunol. 2007;7(6):429–442. PubMed PMID: 17525752.
   PubMed Web of Science ®Google Scholar
• Hashimoto M.Th17 in Animal Models of Rheumatoid Arthritis.J Clin Med.2017;6(7):73; Epub 20170721. PubMed PMID: 28753982; PubMed Central PMCID: PMC5532581;
   PubMed Web of Science ®Google Scholar
• Friedman A, Lam KY.Analysis of a mathematical model of rheumatoid arthritis.J Math Biol.2020;80(6):1857–1883; Epub 20200305. PubMed PMID: 32140775;
   PubMed Web of Science ®Google Scholar
• Mori Y, Mori N, Izumiyama T, et al. Mathematical model for histogram analysis of dynamic contrast-enhanced MRI: a method to evaluate the drug treatment response in rheumatoid arthritis. Eur J Radiol. 2021;141:109831. Epub 20210625. .
   PubMed Web of Science ®Google Scholar
• Ostergaard M, Stoltenberg M, Løvgreen-Nielsen P, et al. Quantification of synovistis by MRI: correlation between dynamic and static gadolinium-enhanced magnetic resonance imaging and microscopic and macroscopic signs of synovial inflammation. Magn Reson Imaging. 1998;16(7):743–754. PubMed PMID: 9811140.
   PubMed Web of Science ®Google Scholar
• Tofts PS, Brix G, Buckley DL, et al. Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging. 1999;10(3):223–232. PubMed PMID: 10508281.
   PubMed Web of Science ®Google Scholar
• Cimmino MA, Innocenti S, Livrone F, et al. Dynamic gadolinium-enhanced magnetic resonance imaging of the wrist in patients with rheumatoid arthritis can discriminate active from inactive disease. Arthritis Rheum. 2003;48(5):1207–1213. PubMed PMID: 12746893.
   PubMedGoogle Scholar
• Hodgson RJ, O’Connor P, Moots R.MRI of rheumatoid arthritis image quantitation for the assessment of disease activity, progression and response to therapy.Rheumatology (Oxford).2008;47(1):13–21; Epub 20071128. PubMed PMID: 18045811;
   PubMed Web of Science ®Google Scholar
• Ochi J, Mori N, Mori Y, et al. Validating an Empirical Mathematical Model for Dynamic Contrast-enhanced MR Imaging of Hand and Wrist Synovitis in Rheumatoid Arthritis: correlation of Model Parameters with Clinical Disease Activity. Magn Reson Med Sci. 2020;19(3):176–183. . PubMed PMID: 31292313; PubMed Central PMCID: PMC7553809
   PubMed Web of Science ®Google Scholar
• Brown AK, Quinn MA, Karim Z, et al. Presence of significant synovitis in rheumatoid arthritis patients with disease-modifying antirheumatic drug-induced clinical remission: evidence from an imaging study may explain structural progression. Arthritis Rheum. 2006;54(12):3761–3773. PubMed PMID: 17133543.
   PubMed Web of Science ®Google Scholar
• Shimizu T, Cruz A, Tanaka M, et al. Structural Changes over a Short Period Are Associated with Functional Assessments in Rheumatoid Arthritis. J Rheumatol. 2019;46(7):676–684. . PubMed PMID: 30770506
   PubMed Web of Science ®Google Scholar